1-[6,6-dimethyl-4-[7-(2-methyl-1H-imidazo[4,5-b]pyridin-6-yl)-3,5-dihydro-2H-1,4-benzoxazepin-4-yl]-7,8-dihydro-5H-quinazolin-2-yl]-N,N-dimethylmethanamine;N,N-dimethyl-1-[4-methyl-6-[7-(2-methyl-3H-pyrrolo[3,2-b]pyridin-6-yl)-3,5-dihydro-2H-1,4-benzoxazepin-4-yl]-5-propan-2-ylpyrimidin-2-yl]methanamine;1-[5-[(4-fluorophenyl)methyl]-4-methyl-6-[7-(2-methyl-3H-indol-6-yl)-3,5-dihydro-2H-1,4-benzoxazepin-4-yl]pyrimidin-2-yl]-N,N-dimethylmethanamine;methyl N-[6-[4-(6,6-dimethyl-7,8-dihydro-5H-quinazolin-4-yl)-3,5-dihydro-2H-1,4-benzoxazepin-7-yl]-1H-imidazo[4,5-b]pyridin-2-yl]carbamate
C117H132FN25O6 — CID 158101213
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[6,6-dimethyl-4-[7-(2-methyl-1H-imidazo[4,5-b]pyridin-6-yl)-3,5-dihydro-2H-1,4-benzoxazepin-4-yl]-7,8-dihydro-5H-quinazolin-2-yl]-N,N-dimethylmethanamine;N,N-dimethyl-1-[4-methyl-6-[7-(2-methyl-3H-pyrrolo[3,2-b]pyridin-6-yl)-3,5-dihydro-2H-1,4-benzoxazepin-4-yl]-5-propan-2-ylpyrimidin-2-yl]methanamine;1-[5-[(4-fluorophenyl)methyl]-4-methyl-6-[7-(2-methyl-3H-indol-6-yl)-3,5-dihydro-2H-1,4-benzoxazepin-4-yl]pyrimidin-2-yl]-N,N-dimethylmethanamine;methyl N-[6-[4-(6,6-dimethyl-7,8-dihydro-5H-quinazolin-4-yl)-3,5-dihydro-2H-1,4-benzoxazepin-7-yl]-1H-imidazo[4,5-b]pyridin-2-yl]carbamate
1-[6,6-dimethyl-4-[7-(2-methyl-1H-imidazo[4,5-b]pyridin-6-yl)-3,5-dihydro-2H-1,4-benzoxazepin-4-yl]-7,8-dihydro-5H-quinazolin-2-yl]-N,N-dimethylmethanamine;N,N-dimethyl-1-[4-methyl-6-[7-(2-methyl-3H-pyrrolo[3,2-b]pyridin-6-yl)-3,5-dihydro-2H-1,4-benzoxazepin-4-yl]-5-propan-2-ylpyrimidin-2-yl]methanamine;1-[5-[(4-fluorophenyl)methyl]-4-methyl-6-[7-(2-methyl-3H-indol-6-yl)-3,5-dihydro-2H-1,4-benzoxazepin-4-yl]pyrimidin-2-yl]-N,N-dimethylmethanamine;methyl N-[6-[4-(6,6-dimethyl-7,8-dihydro-5H-quinazolin-4-yl)-3,5-dihydro-2H-1,4-benzoxazepin-7-yl]-1H-imidazo[4,5-b]pyridin-2-yl]carbamate (PubChem CID 158101213) has the molecular formula C117H132FN25O6 and a molecular weight of 2003.51 g/mol. Its IUPAC name is 1-[6,6-dimethyl-4-[7-(2-methyl-1H-imidazo[4,5-b]pyridin-6-yl)-3,5-dihydro-2H-1,4-benzoxazepin-4-yl]-7,8-dihydro-5H-quinazolin-2-yl]-N,N-dimethylmethanamine;N,N-dimethyl-1-[4-methyl-6-[7-(2-methyl-3H-pyrrolo[3,2-b]pyridin-6-yl)-3,5-dihydro-2H-1,4-benzoxazepin-4-yl]-5-propan-2-ylpyrimidin-2-yl]methanamine;1-[5-[(4-fluorophenyl)methyl]-4-methyl-6-[7-(2-methyl-3H-indol-6-yl)-3,5-dihydro-2H-1,4-benzoxazepin-4-yl]pyrimidin-2-yl]-N,N-dimethylmethanamine;methyl N-[6-[4-(6,6-dimethyl-7,8-dihydro-5H-quinazolin-4-yl)-3,5-dihydro-2H-1,4-benzoxazepin-7-yl]-1H-imidazo[4,5-b]pyridin-2-yl]carbamate.
Molecular Properties
| Compound Name | 1-[6,6-dimethyl-4-[7-(2-methyl-1H-imidazo[4,5-b]pyridin-6-yl)-3,5-dihydro-2H-1,4-benzoxazepin-4-yl]-7,8-dihydro-5H-quinazolin-2-yl]-N,N-dimethylmethanamine;N,N-dimethyl-1-[4-methyl-6-[7-(2-methyl-3H-pyrrolo[3,2-b]pyridin-6-yl)-3,5-dihydro-2H-1,4-benzoxazepin-4-yl]-5-propan-2-ylpyrimidin-2-yl]methanamine;1-[5-[(4-fluorophenyl)methyl]-4-methyl-6-[7-(2-methyl-3H-indol-6-yl)-3,5-dihydro-2H-1,4-benzoxazepin-4-yl]pyrimidin-2-yl]-N,N-dimethylmethanamine;methyl N-[6-[4-(6,6-dimethyl-7,8-dihydro-5H-quinazolin-4-yl)-3,5-dihydro-2H-1,4-benzoxazepin-7-yl]-1H-imidazo[4,5-b]pyridin-2-yl]carbamate |
|---|---|
| PubChem CID | 158101213 |
| Molecular Formula | C117H132FN25O6 |
| Molecular Weight | 2003.51 g/mol |
| Exact Mass | 2002.08 |
| IUPAC Name | 1-[6,6-dimethyl-4-[7-(2-methyl-1H-imidazo[4,5-b]pyridin-6-yl)-3,5-dihydro-2H-1,4-benzoxazepin-4-yl]-7,8-dihydro-5H-quinazolin-2-yl]-N,N-dimethylmethanamine;N,N-dimethyl-1-[4-methyl-6-[7-(2-methyl-3H-pyrrolo[3,2-b]pyridin-6-yl)-3,5-dihydro-2H-1,4-benzoxazepin-4-yl]-5-propan-2-ylpyrimidin-2-yl]methanamine;1-[5-[(4-fluorophenyl)methyl]-4-methyl-6-[7-(2-methyl-3H-indol-6-yl)-3,5-dihydro-2H-1,4-benzoxazepin-4-yl]pyrimidin-2-yl]-N,N-dimethylmethanamine;methyl N-[6-[4-(6,6-dimethyl-7,8-dihydro-5H-quinazolin-4-yl)-3,5-dihydro-2H-1,4-benzoxazepin-7-yl]-1H-imidazo[4,5-b]pyridin-2-yl]carbamate |
| SMILES | CC1=Nc2cc(-c3ccc4c(c3)CN(c3nc(CN(C)C)nc(C)c3C(C)C)CCO4)cnc2C1.CC1=Nc2cc(-c3ccc4c(c3)CN(c3nc(CN(C)C)nc(C)c3Cc3ccc(F)cc3)CCO4)ccc2C1.COC(=O)Nc1nc2ncc(-c3ccc4c(c3)CN(c3ncnc5c3CC(C)(C)CC5)CCO4)cc2[nH]1.Cc1nc2ncc(-c3ccc4c(c3)CN(c3nc(CN(C)C)nc5c3CC(C)(C)CC5)CCO4)cc2[nH]1 |
| InChI | InChI=1S/C33H34FN5O.C29H35N7O.C28H34N6O.C27H29N7O3/c1-21-15-26-8-7-25(18-30(26)35-21)24-9-12-31-27(17-24)19-39(13-14-40-31)33-29(16-23-5-10-28(34)11-6-23)22(2)36-32(37-33)20-38(3)4;1-18-31-24-13-20(15-30-27(24)32-18)19-6-7-25-21(12-19)16-36(10-11-37-25)28-22-14-29(2,3)9-8-23(22)33-26(34-28)17-35(4)5;1-17(2)27-19(4)31-26(16-33(5)6)32-28(27)34-9-10-35-25-8-7-20(12-22(25)15-34)21-13-24-23(29-14-21)11-18(3)30-24;1-27(2)7-6-20-19(12-27)24(30-15-29-20)34-8-9-37-22-5-4-16(10-18(22)14-34)17-11-21-23(28-13-17)32-25(31-21)33-26(35)36-3/h5-12,17-18H,13-16,19-20H2,1-4H3;6-7,12-13,15H,8-11,14,16-17H2,1-5H3,(H,30,31,32);7-8,12-14,17H,9-11,15-16H2,1-6H3;4-5,10-11,13,15H,6-9,12,14H2,1-3H3,(H2,28,31,32,33,35) |
| InChIKey | FPGWBOTVFROPRM-UHFFFAOYSA-N |
| XLogP | 20.58 |
| TPSA | 321.80 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 28 |
| Rotatable Bonds | 18 |
| Heavy Atoms | 149 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2003.51 |
| LogP ≤ 5 | 20.58 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 28 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158101213 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.